Literature DB >> 33817659

Comparison of 68Ga-FAPI versus 18F-FDG PET/CT for Initial Cancer Staging.

Mateus Taveira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33817659      PMCID： PMC8011440          DOI： 10.1148/rycan.2021219007

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN： 2638-616X


× No keyword cloud information.
  1 in total

1.  Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer.

Authors:  Haojun Chen; Yizhen Pang; Jingxun Wu; Liang Zhao; Bing Hao; Jing Wu; Jihong Wei; Siming Wu; Long Zhao; Zuoming Luo; Xuehua Lin; Chengrong Xie; Long Sun; Qin Lin; Hua Wu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-28       Impact factor: 9.236
  1 in total
  3 in total

1.  Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer.

Authors:  Umut Elboga; Ertan Sahin; Tulay Kus; Yusuf Burak Cayirli; Gokmen Aktas; Evren Uzun; Havva Yesil Cinkir; Fatih Teker; Ozlem Nuray Sever; Alper Aytekin; Latif Yilmaz; Aydin Aytekin; Ufuk Cimen; Vuslat Mumcu; Benan Kilbas; Y Zeki Çelen
Journal:  Ann Nucl Med       Date:  2021-08-26       Impact factor: 2.668

2.  The Application of [68Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models.

Authors:  He Zhang; Jiaze An; Pengpeng Wu; Caiqin Zhang; Yong Zhao; Dengxu Tan; Changhong Shi; Xu Ge
Journal:  Contrast Media Mol Imaging       Date:  2022-08-05       Impact factor: 3.009

Review 3.  Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead.

Authors:  Swayamjeet Satapathy; Chandrasekhar Bal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.